ArticleEuropean heart journal. Imaging methods and practice2026
Lung ultrasound guided management in chronic heart failure: an updated systematic review and meta-analysis of randomized controlled trials.
Article in European heart journal. Imaging methods and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ultrasound-guided management in heart failure: A systematic review and meta-analysis evaluating lung and inferior vena cava ultrasound for reducing readmissions and mortality.American heart journal plus : cardiology research and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Existing systematic reviews support the prognostic and therapeutic value of lung ultrasound (LUS) in heart failure (HF), but recent randomized controlled trials (RCTs) in chronic HF justify an up-to-date synthesis. Methods and results: A systematic search of OVID via Medline, SCOPUS, COCHRANE, and CINAHL was conducted from inception until 25 February 2025. The study was registered with PROSPERO (ID: CRD420251003434). RCTs of LUS interventions in patients with chronic HF were included. The primary outcomes were HF urgent visits and HF hospitalizations. Secondary outcomes included mortality, hypokalaemia, and worsening renal function. Five RCTs, involving a total of 694 patients, were included in meta-analyses, with variability in LUS-based definitions of pulmonary congestion across studies. LUS-guided management was associated with a significant reduction in HF urgent visits [RR 0.31 (95% CI 0.17, 0.55), I Conclusion: LUS-guided management is associated with a significant reduction in urgent HF visits and a nonsignificant reduction in HF hospitalizations, with no difference in rates of mortality, hypokalaemia, or worsening renal function. Future studies should aim to establish an optimal, standardized LUS-based definition of pulmonary congestion in chronic HF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.